Skip to main content
. 2013 Apr 16;104(8):1794–1804. doi: 10.1016/j.bpj.2013.02.052

Figure 4.

Figure 4

(A) Concentration of endogenous and exogenous (bound + free) TGF-β1 in cartilage matrix after exposure to 10 ng/mL of exogenous active TGF-β1 or a TGF-β1-free solution (0 ng/mL) for up to 48 h. (B) Concentration of exogenous (bound + free) TGF-β1 in cartilage matrix after exposure to varying levels of exogenous active TGF-β1 (4–450 ng/mL) for 24 h.